Corporate
Hybrid Silica Technologies develops nanostructured silica-based materials with an emphasis on fluorescent core-shell silica nanoparticles which have great potential in bioimaging, diagnostics and many other fields in the life sciences.
HST was founded by researchers in Materials Science & Engineering at Cornell University and a team of entrepreneurs to expand and commercialize the hybrid silica architectures developed at Cornell.
The ongoing development of new nanoscale inorganic/organic hybrid materials enables HST to create products with novel properties for a wide range of applications. We are working with interdisciplinary teams to achieve the required levels of performance and economics for the demands of each application, and connecting with the key players in each field to speed product adoption.
From an end-user perspective, the value proposition of the hybrid silica platform is to make better use of an active agent: protect it so it does not degrade, deliver it to where it can be most effective, amplify its functionality or integrate additional functionalities.
